Find your path to Gabriela
109 people in our graph share verified history with Gabriela — schools, employers, funds. One of them is your warm intro.
Sean KendallunlockedGabriela: together at ロゴマーク:AIRNA (2022–2026)
Gabriela: together at Sophia Genetics
Gabriela: together at The University of Tokyo
Gabriela: together at Haya Therapeutics
Contact· published on Gabriela's own website
Experience
- HAYA TherapeuticsBoard Observercurrent2025 — present
- +ND CapitalPrincipalcurrent2025 — present
- +ND CapitalSenior Associate2023 — 2025
- +ND CapitalAssociate2021 — 2022
- +ND CapitalInnovation Fellow2021
- Constructive BioBoard Observercurrent2025 — present
- Timeline®Board Observercurrent2024 — present
- Notify TherapeuticsBoard Observercurrent2023 — present
- AIRNABoard Observercurrent2022 — present
- Vandria SABoard Observercurrent2021 — present
- EVIR TherapeuticsBoard Observercurrent2021 — present
- Osasuna TherapeuticsBoard Observer2022 — 2025
- CellPointBoard Observer2021 — 2022
- SOPHiA GENETICSGenomics Research Expert2020 — 2021
- SOPHiA GENETICSSenior NGS Scientist2019 — 2020
- SOPHiA GENETICSNGS Scientist2016 — 2019
- EPFL (École polytechnique fédérale de Lausanne)Research Assistant2011 — 2016
- The University of TokyoSummer Intern2015
- Universidade Federal de Santa CatarinaUndergraduate Researcher2006 — 2011Center of Structural and Molecular Biology
Skills & more
Senior Stakeholder ManagementPortfolio ManagementBusiness DevelopmentResearch SkillsHistochemistryNext-Generation Sequencing (NGS)Molecular DiagnosticsProject Management1Business StrategyBioinformaticsVenture CapitalStem Cells5
+11 more
GeneticsGenomicsMolecular BiologyEpigeneticsHigh Throughput ScreeningBiochemistryMolecular CloningPCRStrategic PlanningResearch TranslationSourcing and Due DiligenceLanguages English · French · German · Italian · Portuguese · Spanish
- PRINCE2® Foundation Certification Training — AXELOS Global Best Practice
From Gabriela's professional profile.
Colleagues at +ND Capital
Aditya Rajagopal
Venture Partner at +ND Capital
Alison Palmer
Vice President of the General Partner at +ND Capital
André Châtelain
Advisor at +ND Capital
Aymeric Sallin
Founder and CEO at +ND Capital
Carl Pabo
Advisor at +ND Capital
Cathleen O’Connor
Executive Assistant at +ND Capital
Eric Moessinger
Partner at +ND Capital
Jonathan Nicholson
Executive Director of the General Partner at +ND Capital
Network4
Alison Palmer
Vice President of the General Partner at +ND Capital
Aymeric Sallin
Founder and CEO at +ND Capital
Kirill Kuzmichev
Principal at +ND Capital
Klaus Dugi
Chief Medical Advisor & Venture Partner at +ND Capital
Investors connected to Gabriela in public investor directories — a warm-intro map.
Frequently asked questions
- Who is Gabriela Ecco?
- Principal at +ND Capital
- Where does Gabriela Ecco work?
- Gabriela Ecco is Principal at +ND Capital.
- What check size does Gabriela Ecco write?
- Gabriela Ecco typically writes checks of $100K – $5M.
- Where did Gabriela Ecco go to school?
- Gabriela Ecco studied at EPFL (CAS in Management of Biotech, Medtech & Pharma Ventures); EPFL (Doctor of Philosophy (PhD), PhD in Biotechnology and Bioengineering); Universidade Federal de Santa Catarina (Bachelor of Science (BSc), Biology/Biological Sciences).
Same school
Also attended EPFL188
Raquel UrtasunFounder & CEO of WaabiSteve AnaviCo-founder & President of QontoBouraux LeopoldAI & Data Engineer at Newfund CapitalJan-Olivier FillolsSenior Managing Director at Marlin Equity PartnersChristoph FreiPartner, Head of Energy at Emerald Technology Ventures AgMichael ZehnderHead of Digital Technology & Intelligence at Emerald Technology Ventures Ag
+ 182 more
Also attended Universidade Federal de Santa Catarina20
Luiz Antonio MacariniAI & Machine Learning Engineer at Struck CapitalGustavo NollaFinance Senior Analyst at Valor Capital GroupErwin DassenVenture Partner at FrachtisKatharina FriePartner at eCAPITAL ENTREPRENEURIAL PARTNERSFranco ZanettePartner at ABSeed VenturesSamridhi SinghaniaAVP at IndigoEdge
+ 14 more
Shared employers
Also worked at HAYA Therapeutics9
Sudhir AgrawalInvestor at 82VSBenjamin KreitmanPrincipal at Broadview VenturesThomas NeedhamDirector, Head of the Biopharma Practice at Broadview VenturesDaniel BertholetManaging Partner at 4see VenturesDr. Jens EcksteinAdvisor at Apollo Health VenturesSebastian BernalesGeneral Partner at Humboldt
+ 3 more
Also worked at Timeline®1
Also worked at SOPHiA GENETICS3
Also worked at The University of Tokyo41
Satoshi GojoScientific Advisor at RDiscoveryKarthik VaradaSenior Associate at Beyond Next VenturesNaveed AhmedInvestment Director at Diamond Edge VenturesHiro YoshikawaGeneral Partner at Carbide VenturesAngelina FrankHead of Science & Technology APAC at QAI VenturesAnnie DorisInvestor at E14 Fund
+ 35 more










































.jpg)